Recombinant GDF8 (Lintuzumab Biosimilar) antibody

Catalog No. ABIN7675896

This Human Monoclonal antibody specifically detects GDF8 (Lintuzumab Biosimilar) in Func, BLI, ELISA, FACS and SPR. It exhibits reactivity toward Human.

Quick Overview for Recombinant GDF8 (Lintuzumab Biosimilar) antibody (ABIN7675896)

Target: GDF8 (Lintuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: Un-conjugated

Application: Functional Studies (Func), Bio-Layer Interferometry (BLI), ELISA, Flow Cytometry (FACS), Surface Plasmon Resonance (SPR)

Product Details

Expression System: CHO Cells

Purpose: Anti-Siglec-3 / CD33 Reference Antibody (lintuzumAb)

Characteristics: Anti-Siglec-3 / CD33 Reference Antibody (lintuzumAb) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG1

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details

Target: GDF8 (Lintuzumab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: O14793